Prediction of left lobe hypertrophy after right lobe radioembolization . . . This study aimed to utilize machine learning to predict left lobe liver hypertrophy in patients with HCC and cirrhosis scheduled for right lobe RE, with external validation The results revealed that machine learning can accurately predict relative and absolute volume changes of the left liver lobe after right lobe RE
Prediction of left lobe hypertrophy with voxel-based dosimetry using . . . Purpose The aim of this study was to investigate the relationship between voxel-based dosimetric variables derived from Y-90 PET MRI and hypertrophy observed in the left lobe after radioembolization and to investigate if there is any difference in hypertrophy induced by glass versus resin microspheres Methods Voxel-based dosimetry-derived variables and their relationship with the change of
Prediction of left lobe hypertrophy with voxel-based dosimetry using . . . Following Y-90 radioembolization therapy with glass and resin microspheres applied to the right lobe of the liver, ΔFLR is correlated with pDnorm and Dnorm, but is also significantly related to various nV and pV values In addition, the hypertrophy and kinetic growth rates observed with glass and re …
Prediction of left lobe hypertrophy after right lobe radioembolization . . . To become surgical candidate, hypertrophy of the left liver lobe to > 40% (future liver remnant, FLR) is mandatory, which can develop after RE The amount of radiation-induced shrinkage of the right lobe and compensatory hypertrophy of the left lobe is difficult for clinicians to predict
Baseline left portal vein and left liver lobe size predicts hypertrophy . . . Hypertrophy of the non-malignant segments of liver following PVE is variable Our objective was to determine whether baseline portal vein and liver size assessed on computed tomography (CT) can predict the degree of hypertrophy of the liver lobe following PVE